Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Matt Sirovich And Jeremy Mindich

Activist shareholders continue to be closely-monitored and imitated by investors, given their ability to affect positive change at companies. Whether it be by pressuring companies to set loose underperforming divisions, pushing for change on the company’s Board, or advocating for more of the company’s profits to be distributed to shareholders in the form of share buybacks and/or dividend payments, activist investors know how to move the needle in the right direction. Embedded below and on the following pages is the latest 13D activist filing issued by Matt Sirovich and Jeremy Mindich‘s Scopia Capital, in relation to its position in CONMED Corporation (NASDAQ:CNMD). The filing reveals a new position of 1.69 million shares held by the investment firm, giving them ownership of 6.1% of the issuer’s common stock. The filing does not reveal what plans, if any, Scopia Capital may have in mind regarding its investment.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
SCOPIA PX 434,231 1,693,356 434,231 1,693,356 434,231 1.6%
SCOPIA PARTNERS 12,261 1,693,356 12,261 1,693,356 12,261 Less than 1%
SCOPIA HEALTH CARE 33,666 33,666 33,666 Less than 1%
SCOPIA WINDMILL FUND 309,512 309,512 309,512 1.1%
SCOPIA INTERNATIONAL MASTER FUND 77,391 77,391 77,391 Less than 1%
SCOPIA PX INTERNATIONAL MASTER FUND 558,629 558,629 558,629 2.0%
SCOPIA HEALTH CARE INTERNATIONAL MASTER FUND 245,043 245,043 245,043 Less than 1%
SCOPIA CAPITAL GP 1,670,733 1,670,733 1,670,733 6.0%
SCOPIA CAPITAL MANAGEMENT 1,693,356 1,693,356 1,693,356 6.1%
SCOPIA MANAGEMENT, INC 1,693,356 1,693,356 1,693,356 6.1%
MATTHEW SIROVICH 1,693,356 6.1%
JEREMY MINDICH 1,693,356 6.1%
Matt Sirovich And Jeremy Mindich
Matt Sirovich And Jeremy Mindich
Scopia Capital

Page 1 of 23 SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 1)1
CONMED Corporation
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
207410101
(CUSIP Number)
SAMANTHA NASELLO
SCOPIA CAPITAL MANAGEMENT LP
152 West 57th Street, 33rd Floor
New York, New York 10019
(212) 370-0303
 
STEVE WOLOSKY
OLSHAN FROME WOLOSKY LLP
Park Avenue Tower
65 East 55th Street
New York, New York 10022
(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)
February 19, 2016
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
_______________
1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Conmed Corp (NASDAQ:CNMD)
Trade (NASDAQ:CNMD) Now!
Loading...